MedTrace Logo

A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant

NCT01960361 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2019-07-16

No results posted yet for this study

Summary

The current prospective clinical study's aim is to determine ABT's ICE implant survival rate, crestal interproximal bone resorption during 24 months post implant insertion and to assimilate the drilling sequence during the clinical use of ICE implants.

Conditions

  • Implant Clinical Survival
  • Dental Implant Bone Loss

Interventions

DEVICE

ICE dental implant

ICE- Implant Classical Esthetic implant

Sponsors & Collaborators

  • Alpha - Bio Tec Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-03-31
Completion
2019-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01960361 on ClinicalTrials.gov